Egyptian International Pharmaceutical Industries Company (EGX:PHAR)
Egypt flag Egypt · Delayed Price · Currency is EGP
131.50
-2.32 (-1.73%)
At close: Aug 25, 2026

EGX:PHAR Balance Sheet

Millions EGP. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
217.971,4331,295675.8482.97311.59
Cash & Short-Term Investments
217.971,4331,295675.8482.97311.59
Cash Growth
-86.94%10.66%91.68%39.93%55.00%-57.48%
Accounts Receivable
2,2731,5781,3311,153946.58792.04
Other Receivables
61.99--0.6712.710.95
Receivables
4,0813,3663,0492,3591,8071,172
Inventory
4,4233,8873,5852,2422,1621,818
Other Current Assets
175.83327.75197.91209.39130.2234.32
Total Current Assets
8,8989,0158,1275,4864,5823,536
Property, Plant & Equipment
8,3548,2056,7484,0241,8381,372
Long-Term Investments
1,127675.87465.26466.49352.34326.84
Other Intangible Assets
37.6540.1432.052.31.57-
Long-Term Deferred Tax Assets
361.49337.61----
Other Long-Term Assets
0---0--
Total Assets
18,77818,27315,3739,9796,7745,235

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
854.49766.18381.8138.42185.5660.37
Accrued Expenses
697.36645.86184.12100.8388.4863.29
Short-Term Debt
6,8265,0415,7932,0832,0471,234
Current Portion of Leases
0.450.380.32.191.39-
Current Income Taxes Payable
-388.95344.85184.98106.82110.62
Current Unearned Revenue
83.2273.22----
Other Current Liabilities
720.26864.13540.15321.05230.07192
Total Current Liabilities
9,1827,7807,2442,8312,6601,661
Long-Term Debt
3,2213,7593,4252,832812.13529.07
Long-Term Leases
11.7511.9810.710.130.79-
Long-Term Deferred Tax Liabilities
269.32190.7735.8354.7958.9471.84
Total Liabilities
12,68411,74110,7155,7183,5322,261

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,6881,6881,4881,488991.71991.71
Retained Earnings
3,3953,5491,9041,5081,2861,047
Comprehensive Income & Other
1,0071,0071,2621,262961.82931.82
Total Common Equity
6,0896,2434,6544,2573,2392,971
Minority Interest
4.36288.73.823.393.052.82
Shareholders' Equity
6,0946,5324,6584,2613,2422,973
Total Liabilities & Equity
18,77818,27315,3739,9796,7745,235

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
10,0598,8129,2294,9182,8621,763
Net Cash (Debt)
-9,841-7,379-7,933-4,242-2,379-1,452
Net Cash Growth
------
Net Cash Per Share
-60.69-45.54-53.33-28.52-23.99-14.64
Filing Date Shares Outstanding
168.76168.76148.76148.7699.1799.17
Total Common Shares Outstanding
168.76168.76148.76148.7699.1799.17
Working Capital
-284.11,235883.472,6551,9221,876
Book Value Per Share
36.0837.0031.2828.6232.6629.95
Tangible Book Value
6,0526,2034,6224,2553,2382,971
Tangible Book Value Per Share
35.8636.7631.0728.6032.6529.95
Land
83.1983.1983.1983.1983.19-
Buildings
2,8842,049543.43542.86543.84-
Machinery
3,9732,7782,1581,9831,892-
Construction In Progress
3,3724,9015,6943,058866.16-